Menu Search Site

Tina Liu, M.B.A.


Tina joined the Wyss Institute in 2017 and is working with George Church and Ying Kai Chan to develop safer and more efficacious gene therapies. Prior, Tina was a private equity investor at TPG Capital, where she evaluated potential investments generally $1Bn+ in size across commercial pharma and other sectors of the healthcare industry. Before that, Tina was an investment banker at Morgan Stanley, where she helped advise healthcare companies on key transactions including mergers and acquisitions, equity and debt financings, and other strategic alternatives. Tina received her MBA with Distinction from Harvard Business School and her BA, magna cum laude, from Harvard College.

Close search results
Close menu